Literature DB >> 31049343

Isolated Nail Dystrophy: An Unlikely Presentation of Metastatic Renal Cell Carcinoma.

Sarah F McClees1, James Robert Duncan2, Roger Ceilley3, Tiffani L Milless4, Boni E Elewski2.   

Abstract

Metastasis of any malignancy to the nail unit is uncommon, and only a handful of cases of subungual renal cell carcinoma (RCC) metastasis have been reported. We describe a case of isolated nail dystrophy that proved to be the presenting symptom of a previously undetected RCC. In a patient presenting with a subungual lesion, tumor metastasis to the nail unit should be included in the clinical differential diagnosis in both oncology patients and previously cancer-free individuals, as a subungual metastasis may be the first indication of a clinically silent visceral malignancy.

Entities:  

Keywords:  Nail bed metastasis; Nail tumor; Renal cell carcinoma

Year:  2018        PMID: 31049343      PMCID: PMC6489051          DOI: 10.1159/000495121

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  12 in total

Review 1.  Metastatic tumors to the nail unit: subungual metastases.

Authors:  P R Cohen
Journal:  Dermatol Surg       Date:  2001-03       Impact factor: 3.398

2.  Patterns of skin metastases: a review of 25 years' experience at a single cancer center.

Authors:  Christina Y B Wong; Meghan A Helm; Thomas N Helm; Nathalie Zeitouni
Journal:  Int J Dermatol       Date:  2013-02-22       Impact factor: 2.736

Review 3.  Immunohistochemistry in dermatopathology.

Authors:  Tammie Ferringer
Journal:  Arch Pathol Lab Med       Date:  2015-01       Impact factor: 5.534

Review 4.  [Cutaneous metastasis of renal cell carcinoma: A case report and review of the literature].

Authors:  Paulina Fernández-Rueda; Patricia Ruiz-López; Mario Alberto Ramírez-Negrín; Adán Fuentes-Suárez; Sonia Toussaint-Caire; Ma Elisa Vega-Memije
Journal:  Gac Med Mex       Date:  2015 Jul-Aug       Impact factor: 0.302

Review 5.  Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review.

Authors:  Inmaculada Alcaraz; Lorenzo Cerroni; Arno Rütten; Heinz Kutzner; Luis Requena
Journal:  Am J Dermatopathol       Date:  2012-06       Impact factor: 1.533

Review 6.  Renal cell carcinoma metastatic to the skin.

Authors:  S Koga; S Tsuda; M Nishikido; F Matsuya; Y Saito; H Kanetake
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

Review 7.  The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.

Authors:  Ankur R Sangoi; Jason Karamchandani; Jinah Kim; Reetesh K Pai; Jesse K McKenney
Journal:  Adv Anat Pathol       Date:  2010-11       Impact factor: 3.875

8.  Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients.

Authors:  D P Lookingbill; N Spangler; F M Sexton
Journal:  J Am Acad Dermatol       Date:  1990-01       Impact factor: 11.527

Review 9.  Cutaneous metastases from genitourinary malignancies.

Authors:  Thomas J Mueller; Hong Wu; Richard E Greenberg; Gary Hudes; Neil Topham; Stuart R Lessin; Robert G Uzzo
Journal:  Urology       Date:  2004-06       Impact factor: 2.649

10.  A clinicopathological and immunohistochemical correlation in cutaneous metastases from internal malignancies: a five-year study.

Authors:  Sarita Nibhoria; Kanwardeep Kaur Tiwana; Manmeet Kaur; Sumir Kumar
Journal:  J Skin Cancer       Date:  2014-08-25
View more
  2 in total

Review 1.  Metastases to the nail unit and distal phalanx: a systematic review.

Authors:  Kaya L Curtis; Shari R Lipner
Journal:  Arch Dermatol Res       Date:  2022-10-19       Impact factor: 3.033

2.  Rare Site Hepatocellular Carcinoma Metastasis.

Authors:  Enrique Boldo; Ana Santafe; Araceli Mayol; Rafael Lozoya; Alba Coret; Diana Escribano; Carlos Fortea-Sanchis; Andres Muñoz; Juan Carlos Pastor; Guillermo Perez de Lucia; Nuria Bosch
Journal:  J Hepatocell Carcinoma       Date:  2020-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.